Objective: The aim of this study was to explore the efficacy of percutaneous coronary intervention (PCI) with minimally invasive direct coronary artery bypass grafting (MIDCABG) in the treatment for multivessel coronary artery disease (CAD).
Methods: Clinical data was collected from 208 patients with multivessel CAD involving left anterior descending coronary artery (LAD) who underwent PCI between January 2012 and January 2014. There were 16 patients undergoing two-stage hybrid coronary revascularization (HCR) and another 16 paired patients undergoing PCI alone as control. All the patients in HCR group underwent MIDCABG and 3-7 days antiplatelet therapy followed by PCI.
Results: No death and severe complications were observed in 16 patients undergoing HCR, who had longer hospital stay (11.88 ± 1.15 vs 7.19 ± 1.11 days) and higher medical expense (103186.16 ± 8743.86 vs 64645.66 ± 4929.50 yuan) compared with PCI group. During 3–24 months follow-up, there were no death and myocardial infarction in both groups, but an attack of angina occurred in one patient in PCI group who afterwards underwent coronary angiography and second PCI with implantation of drug-eluting stents due to in-stent restenosis.
Conclusions: Two-stage HCR is a safe, effective and minimally invasive method to treat multivessel CAD.
Manuscripts that are Published Ahead of Print have been peer reviewed and accepted for publication by the Editorial Board of the West Indian Medical Journal. They may appear in their original format and may not be copy edited or formatted in the style guide of this Journal. While accepted manuscripts are not yet assigned a volume, issue or page numbers, they can be cited using the DOI and date of e-publication. See our Instructions for Authors on how to properly cite manuscripts at this stage. The contents of the manuscript may change before it is published in its final form. Manuscripts in this section will be removed once they have been issued to a volume and issue, but will still retain the DOI and date of e-publication.